株式会社日本生物製剤

What 株式会社日本生物製剤 does

Japan Bio Products Co., Ltd. (株式会社日本生物製剤, "JBP") is a Tokyo-based specialist in placenta-based products operating across medical treatment, health, and beauty applications. The company's core asset is its proprietary JBP Placenta Extract, used in its flagship pharmaceutical/health product LAENNEC® (a placental injectable historically associated with Japanese clinics and now shipping into the EU as of March 2026) and in its consumer skincare line, the LNC Cosmetic Series (including LNC DiaSerum). JBP positions itself as the world-leading company in placenta-based products, emphasizing research into placenta composition and mechanism, and maintains product authentication infrastructure to combat counterfeits.

The business operates a hybrid go-to-market model: a direct-to-consumer online shop (jbp-shop-jp.myshopify.com) serves Japanese consumers, while a new channel-partner motion seeks EU distributors for the LNC skincare line following the May 2026 CPNP registration of LNC DiaSerum. Customer segmentation is hybrid, with two primary personas — medical professionals (LAENNEC) and health-and-beauty consumers (LNC) — addressed through distinct channels and product SKUs. The company distributes via its multilingual website (Japanese, English, Simplified and Traditional Chinese), official Facebook and Instagram accounts, and a global online storefront. Pricing is not publicly disclosed.

The company operates with a notably lean team of 7 employees, indicating a small specialist organization rather than a large-scale manufacturer. Financials, headcount trend, funding history, and revenue are not disclosed in the available data. Recent strategic activity in 2026 — EU shipping of LAENNEC, CPNP registration, an EU distributor search, and the discontinuation of JBP Skin Poration — points to a portfolio rationalization and internationalization push centered on the LNC skincare brand and the LAENNEC pharmaceutical product.

Name

株式会社日本生物製剤

Legal name

Japan Bio Products Co., Ltd.

Website

https://jbp.placenta.co.jp

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Japan Bio Products Co., Ltd. is a Tokyo-based specialist in placenta-based products serving medical professionals and beauty consumers through its LAENNEC® pharmaceutical line and LNC Cosmetic Series skincare brands, currently expanding from Japan into the EU market.

Ownership category

akta.pro rank

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Placenta-based Products: Sale of placenta-based products including LAENNEC for medical/aesthetic applications and LNC Cosmetic Series for skincare. Products are distributed through direct online sales and channel partners.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Japan Bio Products Co., Ltd. (JBP) develops, manufactures and sells placenta-based products used in medical treatment, health, and beauty applications. Its commercial lineup centers on proprietary JBP Placenta Extract, encompassing the LAENNEC pharmaceutical/health product, the LNC Cosmetic Series anti-aging skincare brand, and LNC DiaSerum. Products are sold directly to consumers through the company's online shop and through distributor and medical-professional channels.

Product overview

Japan Bio Products Co., Ltd. is a world-leading company specializing in placenta-based products for medical treatment, health, and beauty applications. The company offers a portfolio centered on JBP Placenta Extract as its core ingredient, supported by pharmaceutical/health products like LAENNEC® and skincare brands including the LNC Cosmetic Series (featuring LNC DiaSerum). JBP operates globally with online shop capabilities and is currently expanding into the European market.

Differentiator

Problem solved

Functional benefit

Brands

• LAENNEC®: Placenta-based product brand available for shipping in EU.
• LNC Cosmetic Series
• LNC DiaSerum

Products and services

• JBP Placenta Extract

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• EU Sales Partners/DistributorscoreChannel Partner/ Reseller/ Distributor · 26 May 2026JBP is actively seeking EU sales partners and distributors for their high-quality skincare brand 'LNC Cosmetic Series'. This partnership supports the company's expansion into the European market, with LNC DiaSerum already registered with the European Cosmetics Notification Portal (CPNP). The company is looking for distributors to bring Japanese anti-aging cosmetics to Europe.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• KOSÉ Corporation: Major Japanese cosmetics company operating premium skincare and anti-aging lines (Decorté, Sekkisei, ONE BY KOSÉ), comparable to JBP in serving the premium Japanese skincare consumer with cosmeceutical positioning.
• DHC Corporation:
• FANCL Corporation: Japanese skincare and health supplements company with a strong direct-to-consumer/mail-order model and additive-free beauty positioning, closely mirroring JBP's combination of cosmetic skincare and wellness supplements sold online.
• Pola Orbis Holdings, Inc. Japanese premium cosmetics group with flagship anti-aging brand POLA and a portfolio of skincare brands; comparable to JBP in targeting the high-end Japanese anti-aging skincare consumer with a direct-marketing-leaning model.
• Galderma SA: Global dermatology and medical aesthetics company (Cetaphil, Restylane, Sculptra) operating at the intersection of prescription skincare, aesthetics, and consumer dermocosmetics, comparable to JBP in targeting medical professionals and aesthetic consumers in the medical-beauty crossover.
• Shiseido Co., Ltd. One of Japan's largest global beauty companies with premium anti-aging skincare brands (SHISEIDO, Cle de Peau, ELIXIR) and is likely to overlap with JBP's LNC Cosmetic Series in target customers (anti-aging, premium skincare consumers) and channels.

Regional players

• Hugel, Inc. South Korean biopharmaceutical and medical aesthetics company (botulinum toxin, dermal fillers, skincare) that, like JBP, bridges injectable biologic products with consumer beauty, with comparable premium positioning in the regional medical-aesthetics market.
• Mizon Co., Ltd. South Korean cosmetics company whose portfolio includes placenta-based skincare lines and which sells cross-border into Japan and other Asian markets, comparable to JBP in placenta-derived skincare positioning though in a different primary geography.

Direct peers

• Melsmon Pharmaceutical Co., Ltd. Japan-based pharmaceutical company marketing placenta-based injectable products (Melsmon Injection) for medical and aesthetic use, directly competing with JBP's LAENNEC in the same Japanese placenta-pharma niche.

Emerging players

• BeCur Japan Co., Ltd. Japanese placenta-based cosmetics and supplement brand marketed via D2C channels, an emerging niche specialist with strong overlap to JBP in the Japanese placenta beauty and health category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/japanbioproductscoltd
• Instagraminstagram.com/japanbioproductscoltd
• LinkedInlinkedin.com/company/%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E6%97%A5%E6%9C%AC%E7%94%9F%E7%89%A9%E8%A3%BD%E5%89%A4

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 株式会社日本生物製剤